Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jerusalem Daily Journal.
Press releases published on June 26, 2025
Military 4D Printing Market Size Expected to Reach $673.4 Million by 2040
EIN Presswire
·
June 26, 2025
Military 4D printing market is expected to be valued at $16.1 1million in 2030, and is expected to reach $673.4 million by 2040, growing at a CAGR of 45.2% WILMINGTON, DE, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- By technique, the fused …
Partnerize Acquires Konnecto and Establishes the AI-Powered Future of Partnerships, Sets Sights on 3X Category Growth
EIN Presswire
·
June 26, 2025
Increased R…
Teva Releases Q2 2025 Aide Memoire
GlobeNewswire
·
June 26, 2025
TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2025 Aide Memoire is available on the “Investors” page on its website. Q2 2025 Aide Memoire Teva has prepared this …
Autonomous Navigation Market Size Expected to Reach $15.91 Billion by 2031
EIN Presswire
·
June 26, 2025
Autonomous navigation market was valued at $3.27 billion in 2021, and is estimated to reach $15.91 billion by 2031, growing at a CAGR of 17.1% from 2022 to 2031 WILMINGTON, DE, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- By system, the sensing …
Gauzy Celebrates One Year as a Public Company: Delivering Growth, Innovation, and Long-Term Value Creation
GlobeNewswire
·
June 26, 2025
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ), a global leader in light and vision control technologies, commemorates its one-year anniversary as a publicly traded company, celebrating a transformational 12 months of growth, margin …
Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting
GlobeNewswire
·
June 26, 2025
JERUSALEM, June 26, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced that new data exploring the dual actions of EB613 on trabecular and cortical bone was …